AMGEN - Building Sustainable Trial Access through Deep Site Partnerships

Session details:

Amgen reports on their  collaboration with the Clinical Trial Access Collaborative (CTAC) to expand clinical research access through long‑term, community‑based site partnerships. Attendees will learn:

• How community-based sites are selected, prioritized, and supported with resources and transparent engagement, to bring research directly to communities where many patients receive treatment 

• Early pilot lessons learned and success metrics tied to enrollment, startup, and sustainable research capacity across multiple therapeutic areas – illustrating a scalable model